Literature DB >> 26842752

Predicative Factors for Corneal Endothelial Cell Migration.

Yu Qiang Soh1, Gary Peh2, Benjamin Lawrence George3, Xin Yi Seah3, Nishal Kishinchand Primalani3, Khadijah Adnan3, Jodhbir Singh Mehta4.   

Abstract

PURPOSE: To characterize the effects of Descemet's stripping, Rho-associated protein kinase inhibitor Y-27632, and donor age on endothelial migration in human corneas maintained in ex vivo culture.
METHODS: Twenty-eight cadaveric human corneas underwent ex vivo culture in either standard or Y-27632-supplemented culture medium for 14 days. The posterior surface of each cornea was manipulated to create two types of wounds: scratched wound--corneal endothelial cells (CECs) were denuded from the Descemet's membrane (DM) to leave behind a bare but intact DM; and peeled wound--both the DM and overlying CECs were stripped to leave behind bare corneal stroma. Endothelial migration was assessed via Trypan blue staining. Morphologic traits of CECs were assessed via Alizarin red microscopy and scanning electron microscopy.
RESULTS: The CECs migrated preferentially over scratched wounds compared with peeled wounds. Y-27632 supplementation accelerated endothelial migration over scratched wounds. Endothelial migration decreased with advanced donor age for both wound types, regardless of exposure to Y-27632. Y-27632 supplementation resulted in a less rapid decline in endothelial migration for donors older than 50 years of age for scratched surfaces. Greater cell density and hexagonality was observed over scratched wounds compared with peeled wounds, regardless of Y-27632 supplementation.
CONCLUSIONS: The presence of an intact DM, Y-27632 supplementation, and young donor age are factors that promote endothelial migration in an ex vivo human cornea culture model. The negative effect of age on endothelial migration can be mitigated by the presence of an intact DM and Y-27632 supplementation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26842752     DOI: 10.1167/iovs.15-18300

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

1.  Spontaneous regression of congenital corneal opacity.

Authors:  Sooyeon Choe; Chang Ho Yoon; Mee Kum Kim; Joon Young Hyon; Young Suk Yu; Joo Youn Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-25       Impact factor: 3.117

2.  Keratolenticular adhesion removal for type 2 Peters anomaly: a case report.

Authors:  Zhangliang Li; Rui Zou; Yune Zhao
Journal:  Eye Vis (Lond)       Date:  2020-07-15

3.  Rho-kinase inhibitor Y-27632 facilitates the proliferation, migration and pluripotency of human periodontal ligament stem cells.

Authors:  Ting Wang; Wenyan Kang; Lingqian Du; Shaohua Ge
Journal:  J Cell Mol Med       Date:  2017-06-29       Impact factor: 5.310

Review 4.  Evolution of therapies for the corneal endothelium: past, present and future approaches.

Authors:  Hon Shing Ong; Marcus Ang; Jodhbir Mehta
Journal:  Br J Ophthalmol       Date:  2020-07-24       Impact factor: 4.638

Review 5.  Use of biomaterials in corneal endothelial repair.

Authors:  Noor Ahmed Hussain; Francisco C Figueiredo; Che J Connon
Journal:  Ther Adv Ophthalmol       Date:  2021-12-23

Review 6.  Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.

Authors:  Stephan Ong Tone; Viridiana Kocaba; Myriam Böhm; Adam Wylegala; Tomas L White; Ula V Jurkunas
Journal:  Prog Retin Eye Res       Date:  2020-05-08       Impact factor: 21.198

Review 7.  New Horizons in the Treatment of Corneal Endothelial Dysfunction.

Authors:  Carlos Rocha-de-Lossada; Rahul Rachwani-Anil; Davide Borroni; José-María Sánchez-González; Raquel Esteves-Marques; Fernando-Luis Soler-Ferrández; Jose-Antonio Gegúndez-Fernández; Vito Romano; Eitan Livny; Marina Rodríguez Calvo-de-Mora
Journal:  J Ophthalmol       Date:  2021-07-09       Impact factor: 1.909

8.  Lysophosphatidic acid improves corneal endothelial density in tissue culture by stimulating stromal secretion of interleukin-1β.

Authors:  Yi-Jen Hsueh; Yaa-Jyuhn James Meir; Jui-Yang Lai; Hung-Chi Chen; David Hui-Kang Ma; Chieh-Cheng Huang; Tsai-Te Lu; Chao-Min Cheng; Wei-Chi Wu
Journal:  J Cell Mol Med       Date:  2020-04-24       Impact factor: 5.310

9.  The Rapid Transformation of Transplantation for Corneal Endothelial Diseases: An Evolution From Penetrating to Lamellar to Cellular Transplants.

Authors:  Jie Zhang; Dipika V Patel; Charles N J McGhee
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Nov-Dec

10.  Transcorneal freezing and topical Rho-kinase inhibitor treatment in Fuchs endothelial corneal dystrophy.

Authors:  Johannes Menzel-Severing; Stefan Schrader; Ursula Schlötzer-Schrehardt; Gerd Geerling
Journal:  Eye (Lond)       Date:  2021-04-12       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.